“…This strategy likely provides only a gross assessment of immunologic activity. Moreover, cyclosporine troughs correlate poorly with the area under the curve concentration 9 and may not correlate with intralymphocytic concentration, 27 and thus may not accurately indicate patients at risk for AR, infection, or medication toxicities. As a consequence, additional tests are needed to indicate which patients are at risk.…”